Cefprozil: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 24: | Line 24: | ||
'''| [[Cefprozil clinical studies|Clinical Studies]]''' | '''| [[Cefprozil clinical studies|Clinical Studies]]''' | ||
'''| [[Cefprozil dosage and administration|Dosage and Administration]]''' | '''| [[Cefprozil dosage and administration|Dosage and Administration]]''' | ||
'''| [[Cefprozil how supplied|How Supplied]]''' | '''| [[Cefprozil how supplied|How Supplied]]''' | ||
'''| [[Cefprozil labels and packages|Labels and Packages]]''' | '''| [[Cefprozil labels and packages|Labels and Packages]]''' | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 02:30, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Synonyms: Cefprozilo [INN-Spanish], Cefprozil anhydrous, Cefprozilum [INN-Latin]. A second generation Cephalosporins .It comes either tablet or powder as oral suspension.
Category
Cephalosporins,second generation.
US Brand Names
Cefzil®
Dosing and Administration
Cefprozil tablets and oral suspension are administered orally.
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050664s024,050665s024lbl.pdf